Revolution Medicines (RVMD) Cash from Investing Activities (2019 - 2026)
Revolution Medicines (RVMD) posted Cash from Investing Activities of -$1.7 billion for Q2 2026, down 1060.91% on a QoQ basis from $172.6 million in Q1 2026, and down 4939.16% year-over-year from $34.3 million in Q2 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Revolution Medicines has reported Cash from Investing Activities for 8 years, with the latest figure at -$1.7 billion in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 4939.16% year-over-year to -$1.7 billion in Q2 2026; TTM through Jun 2026 was -$1.4 billion, a 250.04% decrease from a year earlier, with the FY2025 full-year figure at $118.1 million, up 121.29% from the prior year.
- Cash from Investing Activities was -$1.7 billion for Q2 2026 at Revolution Medicines, down from $172.6 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $172.6 million in Q1 2026, with the low at -$1.7 billion in Q2 2026.
- Average Cash from Investing Activities over 5 years is -$127.2 million, with a median of -$1.6 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities jumped 1806.67% in 2022, then tumbled 6305.36% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$7.1 million in 2022, then plunged by 5254.76% to -$380.4 million in 2023, then declined by 3.29% to -$392.9 million in 2024, then soared by 119.06% to $74.9 million in 2025, then plunged by 2315.05% to -$1.7 billion in 2026.
- The last three Cash from Investing Activities figures came in at -$1.7 billion (Q2 2026), $172.6 million (Q1 2026), and $74.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | -1.11 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -1.20 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -5.60 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | -3.11 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -2.91 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | -569.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.35 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 2.11 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | -45.80 Mn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | -1.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.66 Bn |
| Mar 31, 2026 | 172.62 Mn |
| Dec 31, 2025 | 74.88 Mn |
| Sep 30, 2025 | 24.85 Mn |
| Jun 30, 2025 | 34.28 Mn |
| Mar 31, 2025 | -15.95 Mn |
| Dec 31, 2024 | -392.90 Mn |
| Sep 30, 2024 | -21.47 Mn |
| Jun 30, 2024 | 107.94 Mn |
| Mar 31, 2024 | -247.97 Mn |
| Dec 31, 2023 | -380.40 Mn |
| Sep 30, 2023 | 77.35 Mn |
| Jun 30, 2023 | -43.54 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | -7.10 Mn |
| Sep 30, 2022 | -123.44 Mn |
| Jun 30, 2022 | 62.40 Mn |
| Mar 31, 2022 | 44.03 Mn |
| Dec 31, 2021 | 8.53 Mn |
| Sep 30, 2021 | -30.18 Mn |
API Access
Revolution Medicines Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();